Cargando…

Therapeutic alternatives for supporting GPs to deprescribe opioids: a cross-sectional survey

BACKGROUND: GPs are central to opioid strategy in chronic non-cancer pain (CNCP). Lack of treatment alternatives and providers are common reasons cited for not deprescribing opioids. There are limited data about availability of multidisciplinary healthcare providers (MHCPs), such as psychologists, p...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Ruth A, Hayes, Chris, Boyes, Allison W, Chiu, Simon, Paul, Christine L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348329/
https://www.ncbi.nlm.nih.gov/pubmed/30723795
http://dx.doi.org/10.3399/bjgpopen18X101609
_version_ 1783390081669660672
author White, Ruth A
Hayes, Chris
Boyes, Allison W
Chiu, Simon
Paul, Christine L
author_facet White, Ruth A
Hayes, Chris
Boyes, Allison W
Chiu, Simon
Paul, Christine L
author_sort White, Ruth A
collection PubMed
description BACKGROUND: GPs are central to opioid strategy in chronic non-cancer pain (CNCP). Lack of treatment alternatives and providers are common reasons cited for not deprescribing opioids. There are limited data about availability of multidisciplinary healthcare providers (MHCPs), such as psychologists, physiotherapists, or dietitians, who can provide broader treatments. AIM: To explore availability of MHCPs, and the association with GP opioid deprescribing and transition to therapeutic alternatives for CNCP. DESIGN & SETTING: Cross-sectional survey of all practising GPs (N = 1480) in one mixed urban and regional Australian primary health network. METHOD: A self-report mailed questionnaire assessed the availability of MHCPs and management of their most recent patient on long-term opioids for CNCP. RESULTS: Six hundred and eighty-one (46%) valid responses were received. Most GPs (71%) had access to a pain specialist and MHCPs within 50 km. GPs’ previous referral for specialist support was significantly associated with access to a greater number of MHCPs (P = 0.001). Employment of a nurse increased the rate ratio of available MHCPs by 12.5% (incidence rate ratio [IRR] 1.125, 95% confidence interval [CI] = 1.001 to 1.264). Only one-third (32%) of GPs reported willingness to deprescribe and shift to broader CNCP treatments. Availability of MHCPs was not significantly associated with deprescribing decisions. CONCLUSION: Lack of geographical access to known MHCPs does not appear to be a major barrier to opioid deprescribing and shifting toward non-pharmacological treatments for CNCP. Considerable opportunity remains to encourage GPs' decision to deprescribe, with employment of a practice nurse appearing to play a role.
format Online
Article
Text
id pubmed-6348329
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-63483292019-02-05 Therapeutic alternatives for supporting GPs to deprescribe opioids: a cross-sectional survey White, Ruth A Hayes, Chris Boyes, Allison W Chiu, Simon Paul, Christine L BJGP Open Research BACKGROUND: GPs are central to opioid strategy in chronic non-cancer pain (CNCP). Lack of treatment alternatives and providers are common reasons cited for not deprescribing opioids. There are limited data about availability of multidisciplinary healthcare providers (MHCPs), such as psychologists, physiotherapists, or dietitians, who can provide broader treatments. AIM: To explore availability of MHCPs, and the association with GP opioid deprescribing and transition to therapeutic alternatives for CNCP. DESIGN & SETTING: Cross-sectional survey of all practising GPs (N = 1480) in one mixed urban and regional Australian primary health network. METHOD: A self-report mailed questionnaire assessed the availability of MHCPs and management of their most recent patient on long-term opioids for CNCP. RESULTS: Six hundred and eighty-one (46%) valid responses were received. Most GPs (71%) had access to a pain specialist and MHCPs within 50 km. GPs’ previous referral for specialist support was significantly associated with access to a greater number of MHCPs (P = 0.001). Employment of a nurse increased the rate ratio of available MHCPs by 12.5% (incidence rate ratio [IRR] 1.125, 95% confidence interval [CI] = 1.001 to 1.264). Only one-third (32%) of GPs reported willingness to deprescribe and shift to broader CNCP treatments. Availability of MHCPs was not significantly associated with deprescribing decisions. CONCLUSION: Lack of geographical access to known MHCPs does not appear to be a major barrier to opioid deprescribing and shifting toward non-pharmacological treatments for CNCP. Considerable opportunity remains to encourage GPs' decision to deprescribe, with employment of a practice nurse appearing to play a role. Royal College of General Practitioners 2018-11-14 /pmc/articles/PMC6348329/ /pubmed/30723795 http://dx.doi.org/10.3399/bjgpopen18X101609 Text en Copyright © The Authors https://creativecommons.org/licenses/by/4.0/ This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Research
White, Ruth A
Hayes, Chris
Boyes, Allison W
Chiu, Simon
Paul, Christine L
Therapeutic alternatives for supporting GPs to deprescribe opioids: a cross-sectional survey
title Therapeutic alternatives for supporting GPs to deprescribe opioids: a cross-sectional survey
title_full Therapeutic alternatives for supporting GPs to deprescribe opioids: a cross-sectional survey
title_fullStr Therapeutic alternatives for supporting GPs to deprescribe opioids: a cross-sectional survey
title_full_unstemmed Therapeutic alternatives for supporting GPs to deprescribe opioids: a cross-sectional survey
title_short Therapeutic alternatives for supporting GPs to deprescribe opioids: a cross-sectional survey
title_sort therapeutic alternatives for supporting gps to deprescribe opioids: a cross-sectional survey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348329/
https://www.ncbi.nlm.nih.gov/pubmed/30723795
http://dx.doi.org/10.3399/bjgpopen18X101609
work_keys_str_mv AT whiterutha therapeuticalternativesforsupportinggpstodeprescribeopioidsacrosssectionalsurvey
AT hayeschris therapeuticalternativesforsupportinggpstodeprescribeopioidsacrosssectionalsurvey
AT boyesallisonw therapeuticalternativesforsupportinggpstodeprescribeopioidsacrosssectionalsurvey
AT chiusimon therapeuticalternativesforsupportinggpstodeprescribeopioidsacrosssectionalsurvey
AT paulchristinel therapeuticalternativesforsupportinggpstodeprescribeopioidsacrosssectionalsurvey